A carregar...
Targeting insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in metastatic melanoma to increase efficacy of BRAF(V600E) inhibitors
Melanoma is one of the deadliest forms of skin cancer. Although BRAF inhibitors significantly enhance survival of metastatic melanoma patients, most patients relapse after less than a year of treatment. We previously reported that mRNA binding protein Insulin-like growth factor 2 mRNA-binding protei...
Na minha lista:
| Publicado no: | Mol Carcinog |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6408214/ https://ncbi.nlm.nih.gov/pubmed/29369405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mc.22786 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|